Quantcast

Latest pancreatic cancer Stories

2014-10-09 08:28:21

Preclinical Data Indicates Targeting Hyaluronan in the Tumor Stroma May Offer A New Approach to Pancreatic Cancer Treatment SAN DIEGO, Oct. 9, 2014 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced an oral presentation on the pharmacology of PEGPH20 at the New York Academy of Sciences symposium "Targeting Key Vulnerabilities in Pancreatic Cancer," being held on October 9, 2014 in New York City. The presentation includes preclinical data showing that...

2014-10-08 23:01:34

The Firm is evaluating Byetta lawsuits and other legal claims that allege the use of diabetes drugs called incretin mimetics caused patients to develop pancreatic cancer, pancreatitis or thyroid cancer. New York, New York (PRWEB) October 08, 2014 The federal judge overseeing dozens of Byetta lawsuits (http://www.byettalawsuit.com ) and other product liability claims involving incretin mimetic diabetes drugs has denied a request by plaintiffs’ to compel defendants to produce source...

2014-10-04 12:21:14

DALLAS, October 4, 2014 /PRNewswire/ -- ReportsnReports.com adds Global Pancreatic Cancer Market 2014-2018 and Pancreatic Cancer - Pipeline Review, H1 2014 research reports to the pharmaceuticals section of its industry intelligence library. Spread across 97 pages and 956 pages respectively, these reports can be ordered for US$ 2500 each (single user PDF) with ReportsnReports.com at http://www.reportsnreports.com/reports/300141-global-pancreatic-cancer-market-2014-2018.html...

2014-09-30 08:30:50

Urges provinces to move quickly to fund first new treatment for pancreatic cancer approved in Canada in 20 years HALIFAX, Sept. 30, 2014 /CNW/ - Craig's Cause Pancreatic Cancer Society is very pleased that the pan-Canadian Oncology Review (pCODR) has recognized the clinical benefit of Abraxane (nab paclitaxel) in its recently completed review of the new treatment for pancreatic cancer. It urges Canadian provinces to move quickly to work with the drug's manufacturer to ensure it is...

Scientists Identify Early Sign Of Pancreatic Cancer
2014-09-29 03:46:56

Dana-Farber Cancer Institute Scientists at Dana-Farber Cancer Institute, the Massachusetts Institute of Technology, and other institutions have discovered a sign of the early development of pancreatic cancer – an upsurge in certain amino acids that occurs before the disease is diagnosed and symptoms appear. The research is being published online today by the journal Nature Medicine. Although the increase isn't large enough to be the basis of a new test for early detection of the...

2014-09-27 08:21:23

- Afinitor led to an unprecedented median overall survival of 44 months, which represents a clinically meaningful while not statistically significant improvement(1) EAST HANOVER, N.J., Sept. 27, 2014 /PRNewswire/ -- Novartis today presented final results on overall survival (OS) from a Phase III trial of Afinitor(®) (everolimus) tablets plus best supportive care (BSC) compared to placebo plus BSC in patients with well-differentiated advanced and progressive pancreatic...

2014-09-24 23:02:01

The Firm is evaluating Byetta lawsuits and other product liability claims that allege incretin mimetic diabetes drugs caused patients to develop pancreatic cancer, pancreatitis and thyroid cancer. New York, New York (PRWEB) September 24, 2014 Byetta lawsuits(http://www.byettalawsuit.com) and other product liability claims that allege incretin mimetic Type 2 diabetes medications caused patients to develop pancreatic cancer continue to move forward in U.S. courts, Bernstein Liebhard LLP...

chokeberries
2014-09-20 07:08:16

Becky Attwood, University of Southampton A wild berry native to North America may strengthen the effectiveness of a chemotherapy drug commonly used to treat pancreatic cancer, reveals research published online in the Journal of Clinical Pathology. The study by researchers at King’s College Hospital and the University of Southampton suggests that adding nutraceuticals to chemotherapy cycles may improve the effectiveness of conventional drugs, particularly in hard to treat cancers, such...

2014-09-18 08:30:24

FDA Removes Clinical Hold on Phase 2 Clinical Trial SAN DIEGO, Sept. 18, 2014 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that the U.S. Food and Drug Administration (FDA) has removed the clinical hold on patient enrollment and dosing of PEGPH20 in SWOG's ongoing Phase 1b/2 clinical trial (S1313). The trial is designed to evaluate Halozyme's investigational drug PEGPH20 (PEGylated Recombinant Human Hyaluronidase) in combination with modified FOLFIRINOX...

2014-09-16 23:15:45

Seattle’s own Cancer Research And Biostatistics (CRAB), and Translational Drug Development (TD2) in Scottsdale, would like to jointly announce CRAB’s assumption of responsibility for the PCRT, a world-renowned consortium comprised of a team of pancreatic cancer experts committed to improve treatment outcomes for patients with this deadly cancer. Seattle, WA (PRWEB) September 16, 2014 Seattle’s own Cancer Research And Biostatistics (CRAB), and Translational Drug Development (TD2) in...


Latest pancreatic cancer Reference Libraries

Pancreas
2013-01-02 11:22:15

The pancreas is a digestive and an endocrine organ with both endocrine and exocrine functions. It is about six inches long located in the upper portion of the abdominal cavity. The head of the pancreas lies within the indentation of the duodenum and is connected to it by the pancreatic duct. The uncinate process extends from the head and the neck connects to the body of the pancreas, which lies directly behind the stomach. The tail of the pancreas extends to the left side of the body and is...

More Articles (1 articles) »
Word of the Day
reremouse
  • A bat.
The word 'reremouse' comes from Middle English reremous, from Old English hrēremūs, hrērmūs ("bat"), equivalent to rear (“to move, shake, stir”) +‎ mouse.
Related